Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non–cystic fibrosis bronchiectasis: the BAT randomized controlled trial J Altenburg, CS de Graaff, Y Stienstra, JH Sloos, EHJ van Haren, ... Jama 309 (12), 1251-1259, 2013 | 591 | 2013 |
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial WA Nienhuis, Y Stienstra, WA Thompson, PC Awuah, KM Abass, W Tuah, ... The Lancet 375 (9715), 664-672, 2010 | 342 | 2010 |
Mycobacterium ulcerans disease TS van der Werf, Y Stienstra, RC Johnson, R Phillips, O Adjei, B Fleischer, ... Bulletin of the World Health Organization 83, 785-791, 2005 | 224 | 2005 |
Quality of interhospital transport of critically ill patients: a prospective audit JJM Ligtenberg, LG Arnold, Y Stienstra, TS van der Werf, JHJM Meertens, ... Critical Care 9, 1-6, 2005 | 220 | 2005 |
Beliefs and attitudes toward Buruli ulcer in Ghana. Y Stienstra, WTA van der Graaf, K Asamoa, TS van der Werf The American journal of tropical medicine and hygiene 67 (2), 207-213, 2002 | 219 | 2002 |
Risk Factors for Buruli Ulcer Disease (Mycobacterium ulcerans Infection): Results from a Case-Control Study in Ghana PL Raghunathan, EAS Whitney, K Asamoa, Y Stienstra, TH Taylor Jr, ... Clinical Infectious Diseases 40 (10), 1445-1453, 2005 | 205 | 2005 |
Histopathologic features of Mycobacterium ulcerans infection J Guarner, J Bartlett, EAS Whitney, PL Raghunathan, Y Stienstra, ... Emerging infectious diseases 9 (6), 651, 2003 | 192 | 2003 |
Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection WA Nienhuis, Y Stienstra, KM Abass, W Tuah, WA Thompson, PC Awuah, ... Clinical infectious diseases 54 (4), 519-526, 2012 | 128 | 2012 |
Mycolactones and Mycobacterium ulcerans disease TS van der Werf, T Stinear, Y Stienstra, WTA van der Graaf, PL Small The Lancet 362 (9389), 1062-1064, 2003 | 117 | 2003 |
Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors Y Stienstra, WTA Van Der Graaf, GJ Te Meerman, TH The, LF De Leij, ... Tropical Medicine & International Health 6 (7), 554-562, 2001 | 109 | 2001 |
Variability of antibiotic susceptibility and toxin production of Staphylococcus aureus strains isolated from skin, soft tissue, and bone related infections H Sina, TA Ahoyo, W Moussaoui, D Keller, HS Bankolé, Y Barogui, ... BMC microbiology 13, 1-9, 2013 | 99 | 2013 |
Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors ME Hettema, D Zhang, K de Leeuw, Y Stienstra, AJ Smit, CGM Kallenberg, ... Arthritis research & therapy 10, 1-8, 2008 | 90 | 2008 |
Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism Y Stienstra, TS Van Der Werf, E Oosterom, IM Nolte, WTA Van der Graaf, ... Genes & Immunity 7 (3), 185-189, 2006 | 89 | 2006 |
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial RO Phillips, J Robert, KM Abass, W Thompson, FS Sarfo, T Wilson, ... The Lancet 395 (10232), 1259-1267, 2020 | 88 | 2020 |
Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients Y Stienstra, MHG van Roest, MJ van Wezel, IC Wiersma, IC Hospers, ... Tropical Medicine & International Health 10 (12), 1251-1257, 2005 | 87 | 2005 |
Functional limitations after surgical or antibiotic treatment for Buruli ulcer in Benin Y Barogui, RC Johnson, TS van der Werf, G Sopoh, A Dossou, ... American Journal of Tropical Medicine and Hygiene 81 (1), 82, 2009 | 84 | 2009 |
Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members AA Mulder, RP Boerma, Y Barogui, C Zinsou, RC Johnson, J Gbovi, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 102 (9 …, 2008 | 77 | 2008 |
Long term streptomycin toxicity in the treatment of Buruli ulcer: follow-up of participants in the BURULICO drug trial S Klis, Y Stienstra, RO Phillips, KM Abass, W Tuah, TS van der Werf PLoS Neglected Tropical Diseases 8 (3), e2739, 2014 | 76 | 2014 |
Assessment of functional limitations caused by Mycobacterium ulcerans infection: towards a Buruli Ulcer Functional Limitation Score DE Ellen, Y Stienstra, MA Teelken, PU Dijkstra, WTA Van Der Graaf, ... Tropical Medicine & International Health 8 (1), 90-96, 2003 | 73 | 2003 |
Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana BD Westenbrink, Y Stienstra, MG Huitema, WA Thompson, EO Klutse, ... Clinical and Vaccine Immunology 12 (1), 125-129, 2005 | 72 | 2005 |